On the recordJune 30, 1999
I would say that the pharmaceutical industry, which spends over $80 million in the last election cycle in opposition to any serious reform was successful in helping to defeat that proposal. But we will be back, and we are going to be back with another good proposal. That is that one of the outrages that currently exists, as I mentioned earlier, is that the same exact prescription drug manufactured by an American company is sold in Canada, Mexico, and around the world for far lower prices than it is sold in the United States. I know the gentleman intends to release a study in Oregon, but we have already released one in the State of Vermont. What we found is that, for the most commonly used prescription drugs that senior citizens need in Vermont, those drugs cost 81 percent more than in Canada and 112 percent more than in Mexico. And in response to that absurdity, I have introduced legislation which would allow American pharmaceutical distributors to be able to purchase their products from Canada, from Mexico, and from any other country to take advantage of the lower prices so they could resell those products back in the United States at far lower prices than is currently the case. I know the gentleman knows that the problem here is not with the independent pharmacist. That person has no choice but to sell the product for a high price because he is purchasing it for a high price. Well, now we are going to let competition reign.
Source
govinfo.gov




